Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment: Lancet study
New Delhi: Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment ...
Read moreDetails










































